These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

412 related items for PubMed ID: 24533885

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. IgG-induced clustering of desmogleins 1 and 3 in skin of patients with pemphigus fits with the desmoglein nonassembly depletion hypothesis.
    Oktarina DA, van der Wier G, Diercks GF, Jonkman MF, Pas HH.
    Br J Dermatol; 2011 Sep; 165(3):552-62. PubMed ID: 21692763
    [Abstract] [Full Text] [Related]

  • 23. Anti-Desmoglein 1 and 3 Autoantibody Levels in Endemic Pemphigus Foliaceus and Pemphigus Vulgaris from Brazil.
    Oliveira LA, Marquart-Filho A, Trevilato G, Timoteo RP, Mukai M, Roselino AM, Petzl-Erler ML.
    Clin Lab; 2016 Jul 01; 62(7):1209-1216. PubMed ID: 28164651
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Epitope analysis of antidesmoglein 1 autoantibodies from patients with pemphigus foliaceus across different activity stages.
    Kamiya K, Aoyama Y, Yamasaki O, Kamata A, Yamagami J, Iwatsuki K, Tokura Y.
    Br J Dermatol; 2016 Jan 01; 174(1):113-9. PubMed ID: 26294113
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Correlation of antibodies against desmogleins 1 and 3 with indirect immunofluorescence and disease status in a Greek population with pemphigus vulgaris.
    Avgerinou G, Papafragkaki DK, Nasiopoulou A, Markantoni V, Arapaki A, Servitzoglou M, Katsambas A, Stavropoulos PG.
    J Eur Acad Dermatol Venereol; 2013 Apr 01; 27(4):430-5. PubMed ID: 22221266
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Correlation of IgG autoantibodies against acetylcholine receptors and desmogleins in patients with pemphigus treated with steroid sparing agents or rituximab.
    Bhatia SM, Streilein RD, Hall RP.
    PLoS One; 2020 Apr 01; 15(6):e0233957. PubMed ID: 32555697
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Specific immunoadsorption of pathogenic autoantibodies in pemphigus requires the entire ectodomains of desmogleins.
    Yancey KB.
    Dermatol Ther; 2014 Apr 01; 27(5):311. PubMed ID: 25039296
    [No Abstract] [Full Text] [Related]

  • 39. Non-pathogenic pemphigus foliaceus (PF) IgG acts synergistically with a directly pathogenic PF IgG to increase blistering by p38MAPK-dependent desmoglein 1 clustering.
    Yoshida K, Ishii K, Shimizu A, Yokouchi M, Amagai M, Shiraishi K, Shirakata Y, Stanley JR, Ishiko A.
    J Dermatol Sci; 2017 Mar 01; 85(3):197-207. PubMed ID: 28024684
    [Abstract] [Full Text] [Related]

  • 40. Immunoadsorption in pemphigus.
    Eming R, Hertl M.
    Autoimmunity; 2006 Nov 01; 39(7):609-16. PubMed ID: 17101505
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 21.